Memory enhancement and protective effects of crocin against D-galactose aging model in the hippocampus of Wistar rats
محل انتشار: مجله علوم پایه پزشکی ایران، دوره: 20، شماره: 11
سال انتشار: 1396
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 199
فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJBMS-20-11_011
تاریخ نمایه سازی: 28 مهر 1400
چکیده مقاله:
Objective(s): The neurodegeneration and loss of memory function are common consequences of aging. Medicinal plants have potent protective effects against chronic neurodegenerative diseases. The aim of this study was to investigate the beneficial effects and molecular mechanisms of crocin on brain function in D-galactose (D-gal)-induced aging model in rats. Materials and Methods: Male Wistar rats weighing ۲۲۰ ± ۲۰ g were randomly divided into six groups: control, D-gal (۴۰۰ mg/kg, SC), D-gal (۴۰۰ mg/kg) plus crocin (۷.۵, ۱۵, ۳۰ mg/kg, IP) and crocin alone at dose of ۳۰ mg/kg for ۸ weeks. The neuroprotective effects of crocin were evaluated by Morris water maze, determination of malondialdehyde (MDA) levels and Western blot analysis. Results: Crocin significantly inhibited the neurotoxic effects of D-gal through improvement of spatial learning and memory functions as well as the reduction of MDA levels. It was also found that administration of crocin up-regulated pAkt/Akt and pErk/Erk ratio which were decreased by chronic D-gal treatment. In addition, the elevated level of carboxymethyl lysine (CML), as an advance glycation product (AGE), NF-κB p۶۵, TNFα and IL۱β significantly decreased in crocin treated rats compared to D-gal group. Conclusion: These findings suggest that crocin is able to enhance memory function in D-gal aging model through anti-glycative and anti-oxidative properties which finally can suppress brain inflammatory mediators (IL-۱, TNF and NF-κB) formations and increase PI۳K/Akt and Erk/MAPK pathways activity. Therefore, crocin can be considered as healthcare product to prevent age-related brain diseases such as Alzheimer.
کلیدواژه ها:
نویسندگان
Somaye Heidari
Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
Soghra Mehri
Pharmaceutical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Hossein Hosseinzadeh
Pharmaceutical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :